Evidence map›Paper›PMID 38977509›Full record

ArticleEJNMMI physics2024

Timing limits of ultrafast cross-luminescence emission in CsZnCl-based crystals for TOF-CT and TOF-PET.

Katrin Herweg, Daniel Rutstrom, Vanessa Nadig, Luis Stand, Charles L Melcher, Mariya Zhuravleva, Volkmar Schulz, Stefan Gundacker

Abstract read
In one paragraph

Article in EJNMMI physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Katrin HerwegDepartment of Physics of Molecular Imaging Systems, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. katrin.herweg@pmi.rwth-aachen.de.
Daniel RutstromScintillation Materials Research Center, University of Tennessee Knoxville, Knoxville, TN, USA.
Vanessa NadigDepartment of Physics of Molecular Imaging Systems, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany.
Luis StandScintillation Materials Research Center, University of Tennessee Knoxville, Knoxville, TN, USA.
Charles L MelcherScintillation Materials Research Center, University of Tennessee Knoxville, Knoxville, TN, USA.
Mariya ZhuravlevaScintillation Materials Research Center, University of Tennessee Knoxville, Knoxville, TN, USA.
Volkmar SchulzDepartment of Physics of Molecular Imaging Systems, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany.
Stefan GundackerDepartment of Physics of Molecular Imaging Systems, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. stefan.gundacker@pmi.rwth-aachen.de.ORCID http://orcid.org/0000-0003-2087-3266

Funding

Nuclear Science and Security Consortium DE-NA-0003996
6 · The paper itself

Abstract

backgroundGood timing resolution in medical imaging applications such as TOF-CT or TOF-PET can boost image quality or patient comfort significantly by reducing the influence of background noise. However, the timing resolution of state-of-the-art detectors in CT and PET are limited by their light emission process. Core-valence cross-luminescence is an alternative, but well-known compounds (e.g. BaF

resultsIn this work, we investigated two CsZnCl-compounds: Cs

conclusionsThe fast decay time, state-of-the-art CTR in benchtop experiments and high-rate suitability make CsZnCl materials a promising candidate for time-of-flight experiments. We consider especially TOF-CT a suitable application due to its relatively low X-ray energies (~ 100 keV) and the thusly acceptable stopping power of Cs

Indexed as

CsZnClHigh-frequency readoutScintillatorTOF

Identifiers

PMID38977509
PMCPMC11557859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.